First Header Logo Second Header Logo

Connection

Karl-Erik Andersson to Receptors, Purinergic P2

This is a "connection" page, showing publications Karl-Erik Andersson has written about Receptors, Purinergic P2.
Connection Strength

0.523
  1. Imamura T, Ishizuka O, Zhong C, Ogawa T, Nakayama T, Kurizaki Y, Tanabe T, Nishizawa O, Andersson KE. An extract (THC-002) of Ba-Wei-Die-Huang-Wan inhibits expression of tachykinins, and P2X3 and TRPV1 receptors, and inhibits ATP-induced detrusor overactivity in spontaneously hypertensive rats. Neurourol Urodyn. 2009; 28(6):529-34.
    View in: PubMed
    Score: 0.293
  2. Andersson KE, Chapple CR, Höfner K. Future drugs for the treatment of benign prostatic hyperplasia. World J Urol. 2002 Apr; 19(6):436-42.
    View in: PubMed
    Score: 0.184
  3. Andersson KE. Bladder activation: afferent mechanisms. Urology. 2002 May; 59(5 Suppl 1):43-50.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.